Leflunomide 20mgTablet
Musculoskeletal & Orthopedic

Leflunomide 20mg

Leflunomide

Pyrimidine synthesis inhibitor DMARD for rheumatoid arthritis as alternative to methotrexate with less hepatotoxicity. Manufactured by Sun Pharma and Cipla for rheumatology export.

Strengths

10mg / 20mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Leflunomide 10mg / 20mg
Dosage Form
Tablet
Available Strengths
10mg / 20mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
Loading dose: 100mg daily for 3 days (optional); Maintenance: 20mg once daily; reduce to 10mg if not tolerated
Indications
Rheumatoid arthritis, psoriatic arthritis
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C, protect from light
Shelf Life
36 months
Side Effects
Diarrhea, nausea, headache, rash, alopecia, elevated liver enzymes, hypertension
Precautions
Teratogenic — pregnancy excluded before starting; hepatotoxicity monitoring monthly for 6 months; cholestyramine washout procedure if rapid elimination needed; avoid live vaccines; monitor CBC and LFTs

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Leflunomide 20mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote